Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions

Environmental Health Perspectives

Volumn 107, Issue SUPPL. 5, 1999, Pages 667-672

  Powell, Jonathan J ^a   Van De Water, Judy ^a   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; Environmental agents; MHC; Pollution; Self antigen; Xenobiotic

Indexed keywords

ANILIDE; CANAVANINE; IODINE; MAJOR HISTOCOMPATIBILITY ANTIGEN; MERCURY; ORGANIC SOLVENT; OZONE; SILICON DIOXIDE; TRYPTOPHAN; VINYL CHLORIDE; XENOBIOTIC AGENT;

AUTOIMMUNE DISEASE; CONFERENCE PAPER; ENVIRONMENTAL EXPOSURE; GENETIC SUSCEPTIBILITY; HUMAN; LIFESTYLE; PARTICULATE MATTER; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

EID: 0032752889     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.99107s5667     Document Type: Conference Paper

References (66)

1. Luppi P, Rossiello MR, Faas S, Trucco M. Genetic background and environment contribute synergistically to the onset of autoimmune diseases. J Mol Med 73:381-393 (1995).
2. D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114:262-267 (1998).
3. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182-205 (1998).
4. Cooper GS, Dooley MA, Treadwell EL, St. Clair EW, Parks CG Gilkeson GS. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 41:1714-1724 (1998).
5. Berking C, Hobbs MV, Chatelain R, Meurer M, Bell SA. Strain-dependent cytokine profile and susceptibility to oleic acid anilide in a murine model of the toxic oil syndrome. Toxicol Appl Pharmacol 148:222-228 (1998).
6. Clarkson TW. The toxicology of mercury. Crit Rev Clin Lab Sci 34:369-403 (1997).
7. Aschner M, Aschner JL. Mercury neurotoxicity: mechanisms of blood-brain barrier transport. Neurosci Biobehav Rev 14:169-176 (1990).
8. Yoshida S, Gershwin ME. Autoimmunity and selected environmental factors of disease induction. Semin Arthritis Rheum 22:399-419 (1993).
9. Pollard KM, Lee DK, Casiano CA, Bluthner M, Johnston MM, Tan EM. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. J Immunol 158:3521-3528 (1997).
10. Kubicka-Muranyi M, Griem P, Lubben B, Rottmann N. Luhrmann R, Gleichmann E. Mercuric-chloride-induced autoimmunity in mice involves up-regulated presentation by spleen cells of altered and unaltered nucleolar self antigen. Int Arch Allergy Immunol 108:1-10 (1995).
11. Rose NR, Saboori AM, Rasooly L, Burek CL. The role of iodine in autoimmune thyroiditis. Crit Rev Immunol 17:511-517 (1997).
12. Morris JC, Bergert ER, Bryant WP. Binding of immunoglobulin G from patients with autoimmune thyroid disease to rat sodium-iodide symporter peptides: evidence for the iodide transporter as an autoantigen. Thyroid 7:527-534 (1997).
13. Kahaly GJ, Dienes HP, Beyer J, Hommel G. Iodide induces thyroid autoimmunity in patients with endemic goitre: a randomised, double-blind, placebo-controlled trial. Eur J Endocrinol 139:290-297 (1998).
14. Bagchi N, Brawn TR, Sundick RS. Thyroid cell injury is an initial event in the induction of autoimmune thyroiditis by iodine in obese strain chickens. Endocrinology 136:5054-5060 (1995).
15. Rasooly L, Burek CL, Rose NR. Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin Immunol Immunopathol 61:287-292 (1996).
16. Many MC, Maniratunga S, Varis I, Dardenne M, Drexhage HA, Denef JF. Two-step development of Hashimoto-like thyroiditis in genetically autoimmune prone non-obese diabetic mice: effects of iodine-induced cell necrosis. J Endocrinol 147:311-320 (1995).
17. Knobel M, Barca MF, Pedrinola F, Medeiros-Neto G. Prevalence of anti-thyroid peroxidase antibodies in autoimmune and nonautoimmune thyroid disorders in a relatively low-iodine environment. J Endocrinol Invest 17:837-842 (1994).
18. Kong YC, McCormick DJ, Wan Q, Motte RW, Fuller BE, Giraldo AA, David CS. Primary hormonogenic sites as conserved autoepitopes on thyroglobulin in murine autoimmune thyroiditis. Secondary role of iodination. J Immunol 155:5847-5854 (1995).
19. Chiang SY, Swenberg JA, Weisman WH, Skopek TR. Mutagenicity of vinyl chloride and its reactive metabolites, chloroethylene oxide and chloroacetaldehyde, in a metabolically competent human B-lymphoblastoid line. Carcinogenesis 18:31-36 (1997).
20. Lemmark A. Immune surveillance: pareneoplastic or environmental triggers of autoimmunity. Crit Rev Immunol 17:437-447 (1997).
21. Veltman C, Lange CE, Juhe S, Stein G, Bachner V. Clinical manifestations and course of vinyl chloride disease. Ann NY Acad Sci 246:6-17 (1975).
22. Montanaro A, Bardana EJ Jr. Dietary amino acid-induced systemic lupus erythematosus. Rheum Dis Clin North Am 17:323-332 (1991).
23. 1 mice: effects of L-canavanine and a proposed mechanisms for diet-induced autoimmune disease. Can J Physiol Pharmacol 64:1189-1196 (1986).
24. Alcocer-Varela J, Iglesias A, Llorente L. Effects of L-canavanine on T cells may explain the induction of systemic lupus erythematosus by alfalfa. Arthritis Rheum 28:52-57 (1985).
25. Pryor WA, Church DF. Aldehydes, hydrogen peroxide, and organic radicals as mediators of ozone toxicity. Free Radic Biol Med 11:41-46 (1991).
26. Piver WT. Global atmospheric changes. Environ Health Perspect 96:131-137 (1991).
27. Wright ES, Dziedzic D, Wheeler CS, Minireview. Cellular, biochemical and functional effects of ozone: new research and perspectives on ozone health effects. Toxicol Lett 51:125-145 (1989).
28. Zwick H, Popp W, Wagner C. Effects of ozone on the respiratory health, allergic sensitization, and cellular immune system in children. Am Rev Respir Dis 144:1075-1079 (1991).
29. Deeg HJ. Overview. Ultraviolet irradiation in transplantation biology. Manipulation of immunity and immunogenicity. Transplantation 45:845-851 (1988).
30. Jeevan A, Kripke ML. Alteration of the immune response to Mycobacterium bovis BCG in mice exposed chronically to low doses of UV radiation. Cell Immunol 130:32-41 (1990).
31. Behrendt H, Becker WM, Fritzsche C, Sliwa-Tomczok W, Tomczok J, Friedrichs KH, Ring J. Air pollution and allergy: experimental studies on modulation of allergen release from pollen by air pollutants. Int Arch Allergy Immunol 113:69-74 (1997).
32. Clements PJ, Furst DE, eds. Systemic Sclerosis. Baltimore:Williams & Wilkins, 1996.
33. Nieten PJ. Is occupational organic solvent exposure a risk factor for scleroderma? Arth Rheum 41:1111 (1998).
34. Iler RK. The Chemistry of Silica Solubility, Polymerisation, Colloid and Surface Properties, and Biochemistry. New York:John Wiley & Sons, 1979.
35. Carlisle EM. Silicon as an essential element for the chick. Science 178:619-621 (1972).
36. Schwarz K, Milne DB. Growth promoting effects of silicon in rats. Nature 239:333-334 (1972).
37. Hem JD. Geochemistry and aqueous chemistry of aluminum. In: Kidney International, Vol 29 (Coburn JW, Alfrey AC, eds). New York:Springer-Verlag, 1986:S3-S7.
38. Taylor PD, Jugdaohsingh R, Powell JJ. Soluble silica with high affinity for aluminum under physiological and natural conditions. J Am Chem Soc 119:8852-8856 (1997).
39. Yoshida SH, Teuber SS, German JB, Gershwin ME. Immunotoxicity of silicone: implications of oxidant balance towards adjuvant activity. Food Chem Toxicol 32:1089-1100 (1994).
40. Nairn JO, Ippolito KM, van Oss CJ. Adjuvancy effect of different types of silicone get. J Biomed Mater Res 37:534-538 (1997).
41. Nash T, Allison AC, Harington JS. Physico-chemical properties of silica in relation to its toxicity. Nature 210:259-261 (1966).
42. Steenland K, Brown D. Mortality study of gold miners exposed to silica and nonasbestiform amphibole minerals: an update with 14 more years of follow-up. Am J Ind Med 27:217-229 (1995).
43. Koeger AC, Lang T, Alcaix D, Milleron B, Rozenberg S, Chaibi P, Amaud J, Mayaud C, Camus JP, Bourgeois P. Silica-associated connective tissue disease. A study of 24 cases. Medicine 74:221-237 (1995).
44. Brown LM, Gridley G, Olsen JH, Mellemkjaer L, Linet MS, Fraumeni JF Jr. Cancer risk and mortality patterns among silicotic men in Sweden and Denmark. J Occup Environ Med 39:633-638 (1997).
45. Wilke RA, Salisbury S, Abdel-Rahman E, Brazy PC. Lupus-like autoimmune disease associated with silicosis. Nephrol Dial Transplant 11:1835-1838 (1996).
46. Conrad K, Mehlhorn J, Leuthke K, Deorner T, Frank KH. Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines: clinical and serological characteristics. Lupus 5:62-69 (1996).
47. Steenland K, Goldsmith DF. Silica exposure and autoimmune diseases. Am J Ind Med 28:603-608 (1995).
48. Cojocaru M, Niculescu T, Spaetaru E. Study of lung antibodies in patients with silicosis. Romanian J Int Med 33:243-247 (1995).
49. Otsuki T, Sakaguchi H, Tomokuni A, Aikoh T, Matsuki T, Kawakami Y, Kusaka M, Ueki H, Kita S, Ueki A. Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology 94:258-262 (1998).
50. Rao TD, Frey AB. Administration of silica sensitizes lipopolysaccharide responsiveness of murine macrophages but inhibits T and B cell priming by inhibition of antigen presenting function. Immunol Invest 27:181-199 (1998).
51. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960-963 (1997).
52. Strater J, Moller P. Pathogenesis of primary biliary cirrhosis: CD95-induced apoptosis at last? Eur J Gastroenterol Hepatol 10:539-541 (1998).
53. Fubini B. Surface reactivity in the pathogenic response to particulates. Environ Health Perspect 105:1013-1020 (1997).
54. Powell JJ, Ainley CC, Harvey RSJ. Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut 38:390-395 (1996).
55. Ministry of Agriculture Fisheries and Food. Dietary Intake of Food Additives in the UK: Initial Surveillance. Food Surveillance Paper no 37. London:HMSO, 1993.
56. Churg A. The uptake of mineral particles by pulmonary epithelial cells. Am J Respir Crit Care Med 154:1124-1140 (1996).
57. Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharmacol Res 13:1838-1845 (1996).
58. 10). Environ Health Perspect 105:1279-1283 (1997).
59. Vidard L, Kovacsovics-Bankowski M, Kraeft SK, Chen LB, Benacerraf B, Rock KL. Analysis of MHC class II presentation of paniculate antigens by B lymphocytes. J Immunol 156:2809-2818 (1996).
60. + T cell response induced by particulate antigen targeted to phagocytic cells. Int Immunol 9:91-103 (1997).
61. Song R, Hardin CV. Roles of proteasomes, transporter for antigen presentation (TAP) and pymicrogobulin in the processing of bacterial or particulate antigens via an alternative class I MHC processing pathway. J Immunol 156:4182-4190 (1996).
62. Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci USA 90:4942-4946 (1993).
63. Stryhn A, Pedersen L, Romme T. pH dependence of MHC class I-restricted perptide presentation. J Immunol 156:4191-4197 (1996).
64. Maloy KJ, Donachie AM, O'Hagan DT, Mowat AM. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Immunology 81:661-667 (1994).
65. Del Pozo V, de Andraes B, Gallardo S, Caardaba B, de Arruda-Chaves E, Cortegano MI, Jurado A, Palomino P, Oliva H, Aguilera B, et al. Cytokine mRNA expression in lung tissue from toxic oil syndrome patients: a TH2 immunological mechanism. Toxicology 118:61-70 (1997).
66. Bell SA, Hobbs MV, Rubin RL. Isotype-restricted hyperimmunity in a murine model of the toxic oil syndrome. J Immunol 148:3369-3376 (1992).